Coding Ahead
CasePilot
Medical Coding Assistant
Case2Code
Search and Code Lookup Tool
RedactPHI
HIPAA-Compliant PHI Redaction
DetectICD10CM
ICD-10-CM Code Detection
Log in Register free account
1 code page views remaining. Guest accounts are limited to 1 page view. Register free account to get 5 more views.
Log in Register free account

Official Description

Hyperthermia generated by interstitial probe(s); more than 5 interstitial applicators

© Copyright 2025 American Medical Association. All rights reserved.

Common Language Description

Interstitial hyperthermia therapy is a specialized medical procedure aimed at elevating the temperature of tumor cells while minimizing damage to the surrounding healthy tissue. This technique utilizes interstitially placed applicators or probes that generate heat through various methods, including microwave, radiofrequency, or ultrasound energy. The fundamental principle behind this procedure is that tumor cells exhibit a higher sensitivity to increased temperatures compared to normal cells. By raising the temperature of the tumor cells, the therapy can enhance the efficacy of concurrent treatments such as radiation and chemotherapy, and may also stimulate the immune system's components that contribute to the destruction of abnormal cells. This approach is particularly beneficial for treating tumors located deep within the body, such as those found in the lungs or abdominal organs. During the procedure, the patient is placed under anesthesia, and the applicators or probes are carefully inserted into the tumor with the assistance of imaging techniques like x-ray or ultrasound guidance. Once positioned, a heat source is introduced into the applicators or probes, allowing the targeted area to be heated to a predetermined temperature. Following the treatment session, the probes are removed. The coding for this procedure is specific, with CPT® Code 77615 designated for cases involving more than five interstitial applicators, while Code 77610 is used for procedures utilizing five or fewer applicators. This coding encompasses the management of the treatment course, physics planning, insertion of temperature sensors, and the application of heat-generating sources.

© Copyright 2025 Coding Ahead. All rights reserved.

1. Indications

The procedure of interstitial hyperthermia therapy is indicated for various conditions where targeted thermal treatment can be beneficial. The following are the explicitly provided indications for this procedure:

  • Tumors located deep within the body - This includes tumors situated in organs such as the lungs or abdominal structures, where traditional treatment methods may be less effective.
  • Enhancement of radiation therapy - The procedure is performed to increase the effectiveness of radiation treatment by sensitizing tumor cells to radiation through elevated temperatures.
  • Support for chemotherapy - Interstitial hyperthermia can augment the effects of chemotherapy, potentially improving treatment outcomes for patients with certain types of cancer.
  • Immune system stimulation - The therapy may help activate components of the immune system that assist in targeting and destroying abnormal cells, thereby contributing to the overall treatment strategy.

2. Procedure

The interstitial hyperthermia therapy procedure involves several critical steps to ensure effective treatment. The following outlines the procedural steps as described:

  • Step 1: Patient Preparation - The patient is first prepared for the procedure, which includes obtaining informed consent and ensuring that the patient is under anesthesia to minimize discomfort during the treatment.
  • Step 2: Imaging Guidance - Using imaging techniques such as x-ray or ultrasound, the physician identifies the precise location of the tumor within the body. This step is crucial for the accurate placement of the applicators or probes.
  • Step 3: Insertion of Applicators/Probes - Once the tumor is located, the physician carefully inserts the interstitial applicators or probes into the tumor. This is done with precision to ensure that the heat will be effectively delivered to the targeted area.
  • Step 4: Heat Source Application - After the applicators or probes are in place, a heat-generating source is introduced into them. This source can utilize microwave, radiofrequency, or ultrasound energy to elevate the temperature of the tumor cells to the desired therapeutic level.
  • Step 5: Monitoring and Adjustment - Throughout the procedure, the physician monitors the temperature and the effectiveness of the heat application, making any necessary adjustments to ensure optimal treatment.
  • Step 6: Removal of Probes - At the conclusion of the treatment session, the applicators or probes are carefully removed from the patient, and post-procedure care is initiated.

3. Post-Procedure

After the interstitial hyperthermia therapy is completed, the patient may require specific post-procedure care to ensure proper recovery. This may include monitoring for any immediate side effects or complications related to the procedure. Patients are typically advised to rest and may be given instructions regarding pain management, wound care, and follow-up appointments to assess the effectiveness of the treatment. It is essential to evaluate the patient's response to the therapy and to plan any subsequent treatments, such as radiation or chemotherapy, as part of a comprehensive cancer care strategy.

Short Descr HYPERTHERMIA NTRSTL PRB>5
Medium Descr HYPERTHERMIA INTERSTIAL PROBE>5 APPLICATORS
Long Descr Hyperthermia generated by interstitial probe(s); more than 5 interstitial applicators
Status Code Restricted Coverage
Global Days XXX - Global Concept Does Not Apply
PC/TC Indicator (26, TC) 1 - Diagnostic Tests for Radiology Services
Multiple Procedures (51) 0 - No payment adjustment rules for multiple procedures apply.
Bilateral Surgery (50) 0 - 150% payment adjustment for bilateral procedures does NOT apply.
Physician Supervisions 09 - Concept does not apply.
Assistant Surgeon (80, 82) 0 - Payment restriction for assistants at surgery applies to this procedure...
Co-Surgeons (62) 0 - Co-surgeons not permitted for this procedure.
Team Surgery (66) 0 - Team surgeons not permitted for this procedure.
Diagnostic Imaging Family 99 - Concept Does Not Apply
APC Status Indicator Procedure or Service, Not Discounted when Multiple
ASC Payment Indicator Radiology service paid separately when provided integral to a surgical procedure on ASC list; payment based on OPPS relative payment weight.
Type of Service (TOS) 6 - Therapeutic Radiology
Berenson-Eggers TOS (BETOS) P7B - Oncology - other
MUE 1
CCS Clinical Classification 211 - Therapeutic radiology
26 Professional component: certain procedures are a combination of a physician or other qualified health care professional component and a technical component. when the physician or other qualified health care professional component is reported separately, the service may be identified by adding modifier 26 to the usual procedure number.
Date
Action
Notes
2025-01-01 Changed Short and Medium Descriptions changed.
2017-01-01 Changed Moderate (Conscious) Sedation flag removed. See new Moderate Sedation category.
Pre-1990 Added Code added.
Code
Description
Code
Description
CasePilot

Get instant expert-level medical coding assistance.

Ask about:
CPT Codes Guidelines Modifiers Crosswalks NCCI Edits Compliance Medicare Coverage
Example: "What is CPT code 99213?" or "Guidelines for E/M services"